Ascendis Pharma A (ASND) Interest Coverage Ratio Growth (3y) (2017 - 2026)

Ascendis Pharma A (ASND) Interest Coverage Ratio Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -42.41%
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 28.11%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -6.89%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 79.27%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 29.47%
10 Ascendis Pharma A 15.35 Bn 14.68 Bn 268.20 Mn 26.52%

Historic Data

Download Data
DateValue
Mar 31, 2026 26.52%
Dec 31, 2025 -96.11%
Sep 30, 2025 63.93%
Jun 30, 2025 52.58%
Mar 31, 2025 53.88%
Dec 31, 2024 -4,577.26%
Sep 30, 2024 26.71%
Jun 30, 2024 11.17%
Mar 31, 2024 83.56%
Dec 31, 2023 -26.33%
Sep 30, 2023 -68.45%
Jun 30, 2023 -57.03%
Mar 31, 2023 55.33%
Dec 31, 2022 38.37%
Sep 30, 2022 -26.49%
Jun 30, 2022 -64.82%
Mar 31, 2022 56.60%
Dec 31, 2021 29.75%
Sep 30, 2021 -28.49%
Jun 30, 2021 -26.02%